GLP-1 Receptor Agonists Increase Risk of Pulmonary Aspiration During Anesthesia

A new UK study reveals that patients taking GLP-1 receptor agonists (GLP-1 RAs)—medications commonly used to treat diabetes and obesity—face an increased risk of pulmonary aspiration and regurgitation during anesthesia. The research, presented at the Association of Anaesthetists annual meeting, found that 2.9% of anesthesia patients were using these medications. Pulmonary aspiration occurs when stomach contents enter the lungs during surgery, potentially causing serious complications. Anesthesiologists recommend that patients inform their surgical teams about GLP-1 RA use beforehand to ensure appropriate safety precautions are implemented during procedures.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: October 3, 2026 at 10:00 AM



